The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Human Immunodeficiency Virus Type 1 V1-V2 Envelope Loop Sequences Expand and Add Glycosylation Sites over the Course of Infection, and These Modifications Affect Antibody Neutralization Sensitivity
Open accessAbstract
Over the course of infection, human immunodeficiency virus type 1 (HIV-1) continuously adapts to evade the evolving host neutralizing antibody responses. Changes in the envelope variable loop sequences, particularly the extent of glycosylation, have been implicated in antibody escape. To document modifications that potentially influence antibody susceptibility, we compared envelope variable loops 1 and 2 (V1-V2) from multiple sequences isolated at the primary phase of infection to those isolated around 2 to 3 years into the chronic phase of infection in nine women with HIV-1 subtype A. HIV-1 sequences isolated during chronic infection had significantly longer V1-V2 loops, with a significantly higher number of potential N-linked glycosylation sites, than the sequences isolated early in infection. To assess the effects of these V1-V2 changes on antibody neutralization and infectivity, we created chimeric envelope sequences, which incorporated a subject's V1-V2 sequences into a common subtype A envelope backbone and then used them to generate pseudotyped viruses. Compared to the parent virus, the introduction of a subject's early-infection V1-V2 envelope variable loops rendered the chimeric envelope more sensitive to that subject's plasma samples but only to plasma samples collected >6 months after the sequences were isolated. Neutralization was not detected with the same plasma when the early-infection V1-V2 sequences were replaced with chronic-infection V1-V2 sequences, suggesting that changes in V1-V2 contribute to antibody escape. Pseudotyped viruses with V1-V2 segments from different times in infection, however, showed no significant difference in neutralization sensitivity to heterologous pooled plasma, suggesting that viruses with V1-V2 loops from early in infection were not inherently more neutralization sensitive. Pseudotyped viruses bearing chimeric envelopes with early-infection V1-V2 sequences showed a trend in infecting cells with low CD4 concentrations more efficiently, while engineered viruses with V1-V2 sequences isolated during chronic infection were moderately better at infecting cells with low CCR5 concentrations. These studies suggest that changes within the V1-V2 envelope domains over the course of an infection influence sensitivity to autologous neutralizing antibodies and may also impact host receptor/coreceptor interactions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kwong, P. D., Wyatt, R., Robinson, J., Sweet, R. W., Sodroski, J., & Hendrickson, W. A. (1998) · Nature · doi:10.1038/31405 · Cited by 2,964
Antibody neutralization and escape by HIV-1
Wei, X., Decker, J. M., Wang, S., Hui, H., Kappes, J. C., Wu, X., Salazar-Gonzalez, J. F., Salazar, M. G., Kilby, J. M., Saag, M. S., et al. (2003) · Nature · doi:10.1038/nature01470 · Cited by 2,421
Self-citationWei, X., Decker, J. M., Liu, H., Zhang, Z., Arani, R. B., Kilby, J. M., Saag, M. S., Wu, X., Shaw, G. M., & Kappes, J. C. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1896-1905.2002 · Cited by 1,569 · cited 1×
“TZM-bl is a HeLa-based cell line that has been genetically engineered to stably express high levels of CD4 and CCR5; in addition, TZM-bl cells express Escherichia coli -galactosidase under the transcriptional control of the HIV-1 long terminal repeat ( 42 ).”
BackgroundSelf-citationPlatt, E. J., Wehrly, K., Kuhmann, S. E., Chesebro, B., & Kabat, D. (1998) · Journal of Virology · doi:10.1128/jvi.72.4.2855-2864.1998 · Cited by 1,219
The antigenic structure of the HIV gp120 envelope glycoprotein
Wyatt, R., Kwong, P. D., Desjardins, E., Sweet, R. W., Robinson, J., Hendrickson, W. A., & Sodroski, J. G. (1998) · Nature · doi:10.1038/31514 · Cited by 1,203
Rapid evolution of the neutralizing antibody response to HIV type 1 infection
Richman, D. D., Wrin, T., Little, S. J., & Petropoulos, C. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0630530100 · Cited by 1,200
Kimpton, J., & Emerman, M. (1992) · Journal of Virology · doi:10.1128/jvi.66.4.2232-2239.1992 · Cited by 908
CCR5 Levels and Expression Pattern Correlate with Infectability by Macrophage-tropic HIV-1, In Vitro
Wu, L., Paxton, W. A., Kassam, N., Ruffing, N., Rottman, J. B., Sullivan, N., Choe, H., Sodroski, J., Newman, W., Koup, R. A., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.9.1681 · Cited by 694
Envelope-Constrained Neutralization-Sensitive HIV-1 After Heterosexual Transmission
Derdeyn, C. A., Decker, J. M., Bibollet-Ruche, F., Mokili, J. L., Muldoon, M., Denham, S. A., Heil, M. L., Kasolo, F., Musonda, R., Hahn, B. H., et al. (2004) · Science · doi:10.1126/science.1093137 · Cited by 617
Gain of Virulence Caused by Loss of a Gene in Murine Cytomegalovirus
Bubić, I., Wagner, M., Krmpotić, A., Saulig, T., Kim, S., Yokoyama, W. M., Jonjić, S., & Koszinowski, U. H. (2004) · Journal of Virology · doi:10.1128/jvi.78.14.7536-7544.2004 · Cited by 569
A role for carbohydrates in immune evasion in AIDS
Reitter, J. N., Means, R. E., & Desrosiers, R. C. (1998) · Nature Medicine · doi:10.1038/nm0698-679 · Cited by 558
Modrow, S., Hahn, B. H., Shaw, G. M., Gallo, R. C., Wong-Staal, F., & Wolf, H. (1987) · Journal of Virology · doi:10.1128/jvi.61.2.570-578.1987 · Cited by 441
Identifying epitopes of HIV-1 that induce protective antibodies
Zolla-Pazner, S. (2004) · Nature Reviews Immunology · doi:10.1038/nri1307 · Cited by 326
Capsid Is a Dominant Determinant of Retrovirus Infectivity in Nondividing Cells
Yamashita, M., & Emerman, M. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.5670-5678.2004 · Cited by 325 · cited 2×
“To assess the impact of V1-V2 changes on viral entry, we created pseudotyped viruses with the chimeric envelopes and the BRU EnvGFP construct (47) and examined their infectivities in cell lines expressing various amounts of CD4 and CCR5 (25).”
BackgroundMethodShakin-Eshleman, S. H., Spitalnik, S. L., & Kasturi, L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.11.6363 · Cited by 318
Wu, X., Parast, A. B., Richardson, B. A., Nduati, R., John-Stewart, G., Mbori-Ngacha, D., Rainwater, S. M. J., & Overbaugh, J. (2006) · Journal of Virology · doi:10.1128/jvi.80.2.835-844.2006 · Cited by 274
Self-citationMartin, Jr., Nyange, P. M., Richardson, B. A., Lavreys, L., Mandaliya, K., Jackson, D. J., Ndinya‐Achola, J. O., & Kreiss, J. (1998) · The Journal of Infectious Diseases · doi:10.1086/515654 · Cited by 269
Pinter, A., Honnen, W. J., He, Y., Gorny, M. K., Zolla-Pazner, S., & Kayman, S. C. (2004) · Journal of Virology · doi:10.1128/jvi.78.10.5205-5215.2004 · Cited by 248
Pollakis, G., Kang, S., Kliphuis, A., Chalaby, M. I. M., Goudsmit, J., & Paxton, W. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009779200 · Cited by 235
Moog, C., Fleury, H. J., Pellegrin, I., Kirn, A., & Aubertin, A. M. (1997) · Journal of Virology · doi:10.1128/jvi.71.5.3734-3741.1997 · Cited by 232
Cao, J., Sullivan, N., Desjardin, E., Parolin, C., Robinson, J., Wyatt, R., & Sodroski, J. (1997) · Journal of Virology · doi:10.1128/jvi.71.12.9808-9812.1997 · Cited by 219
Chackerian, B., Rudensey, L. M., & Overbaugh, J. (1997) · Journal of Virology · doi:10.1128/jvi.71.10.7719-7727.1997 · Cited by 207
Self-citationZhang, L., He, T., Talal, A., Wang, G., Frankel, S. S., & Ho, D. D. (1998) · Journal of Virology · doi:10.1128/jvi.72.6.5035-5045.1998 · Cited by 196
Kasturi, L., Eshleman, J. R., Wunner, W. H., & Shakin-Eshleman, S. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.24.14756 · Cited by 161
Bartz, S. R., & Vodicka, M. A. (1997) · Methods · doi:10.1006/meth.1997.0487 · Cited by 158
Stamatatos, L., & Cheng‐Mayer, C. (1998) · Journal of Virology · doi:10.1128/jvi.72.10.7840-7845.1998 · Cited by 152
Toohey-Kurth, K. L., Wehrly, K., Nishio, J., Perryman, S., & Chesebro, B. W. (1995) · Virology · doi:10.1006/viro.1995.1547 · Cited by 151
Ly, A., & Stamatatos, L. (2000) · Journal of Virology · doi:10.1128/jvi.74.15.6769-6776.2000 · Cited by 150
Sagar, M., Lavreys, L., Baeten, J. M., Richardson, B. A., Mandaliya, K. N., Chohan, B. H., Kreiss, J. K., & Overbaugh, J. M. (2003) · Journal of Virology · doi:10.1128/jvi.77.23.12921-12926.2003 · Cited by 120
Self-citationHIV-1 Entry and Its Inhibition
Pierson, T. C., & Doms, R. W. (2003) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-19012-4_1 · Cited by 117
Pugach, P., Kuhmann, S. E., Taylor, J., Marozsan, A. J., Snyder, A., Ketas, T. J., Wolinsky, S. M., Korber, B., & Moore, J. P. (2004) · Virology · doi:10.1016/j.virol.2003.12.012 · Cited by 84
Johnson, W. E., Morgan, J., Reitter, J. N., Puffer, B. A., Czajak, S. C., Doms, R. W., & Desrosiers, R. C. (2002) · Journal of Virology · doi:10.1128/jvi.76.5.2075-2086.2002 · Cited by 83
Poss, M. L., & Overbaugh, J. M. (1999) · Journal of Virology · doi:10.1128/jvi.73.7.5255-5264.1999 · Cited by 81
Self-citationShioda, T., Oka, S., Xin, X., Liu, H., Harukuni, R., Kurotani, A., Fukushima, M., Hasan, M. K., Shiino, T., Takebe, Y., et al. (1997) · Journal of Virology · doi:10.1128/jvi.71.7.4871-4881.1997 · Cited by 80
Surface CD4 Is Critical to in Vitro HIV Infection of Human Alveolar Macrophages
Lewin, S. R., Sonza, S., Irving, L., McDonald, C. F., MILLS, J. S., & Crowe, S. M. (1996) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1996.12.877 · Cited by 64
Puryear, W. B., Gnanakaran, S., Foley, B. T., Doria‐Rose, N. A., Korber, B., & Haigwood, N. L. (2005) · Journal of Virology · doi:10.1128/jvi.80.2.999-1014.2006 · Cited by 64
Walter, B. L., Wehrly, K., Swanstrom, R. I., Platt, E. J., Kabat, D., & Chesebro, B. W. (2005) · Journal of Virology · doi:10.1128/jvi.79.8.4828-4837.2005 · Cited by 62
Sagar, M., Kirkegaard, E., Lavreys, L., & Overbaugh, J. M. (2006) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2006.22.430 · Cited by 27
Self-citation
Cited by
Corti, D., Voss, J., Gamblin, S. J., Codoni, G., Macagno, A., Jarrossay, D., Vachieri, S. G., Pinna, D., Minola, A., Vanzetta, F., et al. (2011) · Science · doi:10.1126/science.1205669 · Cited by 1,203
Phylogeny-Aware Gap Placement Prevents Errors in Sequence Alignment and Evolutionary Analysis
Löytynoja, A., & Goldman, N. (2008) · Science · doi:10.1126/science.1158395 · Cited by 802
The Challenge of HIV-1 Subtype Diversity
Taylor, B. S., Sobieszczyk, M. E., McCutchan, F. E., & Hammer, S. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0706737 · Cited by 635
Salazar-Gonzalez, J. F., Bailes, E., Pham, K. T., Salazar, M. G., Guffey, M. B., Keele, B. F., Derdeyn, C. A., Farmer, P., Hunter, E., Allen, S., et al. (2008) · Journal of Virology · doi:10.1128/jvi.02660-07 · Cited by 596
Virus glycosylation: role in virulence and immune interactions
Vigerust, D. J., & Shepherd, V. L. (2007) · Trends in Microbiology · doi:10.1016/j.tim.2007.03.003 · Cited by 588
Metadata
- Authors
- Sagar, M., Wu, X., Lee, S., & Overbaugh, J.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2006-10
- Volume
- 80
- Issue
- 19
- Pages
- 9586-9598
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2126887491
- Cited by
- 308
- References
- 38
- FWCI
- 5.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.